EVALUATION OF KALLISTATIN AS A BIOMARKER IN CHRONIC HEPATITIS C PATIENTS
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 9
Abstract
Early outcome prediction after hepatitis C viral infections has a great interest. This study aims to evaluate kallistatin in the prediction of liver fibrosis in chronic hepatitis C Egyptian patients. This study included 62 patients with chronic HCV infection (30 patients suffering from early liver fibrosis, 16 with advanced liver fibrosis, 16 with HCC) and 14 healthy subjects. Serum liver function tests were determined by colorimetric methods, HBsAg, HCVAb, AFP, CRP and kallistatin were investigated by ELISA, HCV-RNA and the expression of SERPINA4 gene were determined by qRT-PCR assay, abdominal ultrasound and ultrasonic-guided liver biopsy were done to determine the stage of fibrosis. Serum kallistatin level was significantly lower in patients with chronic liver disease (CLD) than healthy subjects at the gene expression and protein levels (P=0.003 & 0.001, respectively). Also, there was a significant difference in kallistatin concentration in early and advanced fibrosis, (p=0.044). Serum kallistatin had greater sensitivity and NPV values than did AST/ALT ratio (AAR) and AST/platelet ratio index (APRI) in patients with CLD compared with healthy subjects with sensitivity 95.1%, specificity 50%, PPV 89.2%, and NPV 70%. Moreover, Kallistatin could significantly distinguish patients at early stage of liver fibrosis from healthy subjects with sensitivity 96.7% and specificity 50%. Compared with single detection, combined measurement of the AAR, APRI and kallistatin markers showed 90% sensitivity and 78.6% specificity, 90% PPV and 78.6% NPV. These data support that kallistatin may be an efficient biomarker in early detection of fibrosis. Also, it suggested that combination of kallistatin with AAR and APRI could improve the sensitivity and specificity for the diagnosis of CLD and this can be used as a practical method for clinical diagnosis for the early stage of liver fibrosis.
Authors and Affiliations
Halla M. Ragab & Wafaa Abd Elaziz
Keywords
Related Articles
- EP ID EP618642
- DOI -
- Views 146
- Downloads 0
ROLE OF DRUG REGULATORY AFFAIRS IN PHARMA INDUSTRY
Drug Regulatory Affairs (DRA) is a vital unit in a pharmaceutical company as it is concern about the healthcare of people and shelf life of product. it provide planned, premeditated and prepared direction and support for...
CANCER CAUSED BY DUSHIVISHA AS A LIFE STYLE DISORDER
Ayurveda, the science of healthful living, is the most rational and scientific among the ancient systems of medicine. Ayurveda has immense potential to tackle many medical problems. Agadtantra is the branch of Astangaayu...
PREVALANCE OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS UNDERGOING ECHO CARIOGRAPHY
Left ventricular hypertrophy is an important predictor of cardiovascular risk, and its detection contributes to risk stratification. The aims of the study were to evaluate the prevalence of left ventricular hypertrophy i...
AN OVERVIEW OF POLYAMIDOAMINE DENDRIMERS: STRUCTURE, PHYSICAL PROPERTIES, AND BIOMEDICAL APPLICATIONS
Polyamidoamine (PAMAM) dendrimers are the primary complete dendrimer family to be orchestrated, described and marketed. Dendrimers are hyper branched, monodispersed macromolecules with multivalent useful end bunches. Den...
A COMPUTATIONAL STUDY ON MOLECULAR GEOMETRIES, CHEMISTRY REACTIVITY DESCRIPTORS OF TTP DERIVATIVES
The optimized molecular structures of TTP derivatives 1-4 have been investigated theoretically using Gaussian 09 software package. The HOMO and LUMO analysis is used to determine the charge transfer within the molecules....